Bank of New York Mellon »

Bicara Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 85k 15.79
2025-06-30 $747k 80k 9.29
2025-03-31 $550k 42k 13.03
2024-12-31 $702k 40k 17.42

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics